STATE STREET CORP - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 39 filers reported holding SAB BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$51,182
-24.1%
81,2410.0%0.00%
Q2 2023$67,430
+88.6%
81,2410.0%0.00%
Q1 2023$35,746
-62.7%
81,241
-50.0%
0.00%
Q4 2022$95,848
+68.2%
162,482
+100.0%
0.00%
Q3 2022$57,000
-51.7%
81,2410.0%0.00%
Q2 2022$118,000
-25.8%
81,241
+91.9%
0.00%
Q1 2022$159,000
+65.6%
42,341
+244.2%
0.00%
Q4 2021$96,00012,3000.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
First PREMIER Bank 832,555$6,502,0001.68%
Radcliffe Capital Management, L.P. 546,658$5,521,0000.14%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 78,115$610,0000.10%
Shaolin Capital Management LLC 239,750$1,872,0000.05%
Nadler Financial Group, Inc. 11,000$86,0000.01%
Virtu Financial LLC 15,379$120,0000.01%
Spectrum Management Group, LLC 5,030$39,0000.01%
Veritable, L.P. 43,551$340,0000.01%
ALPS ADVISORS INC 50,306$393,0000.00%
ETF MANAGERS GROUP, LLC 13,202$105,0000.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders